Airfinity is a first of its kind disease forecasting company. We aim to predict disease outbreaks in the same way the weather, travel and financial markets are forecast. In 2020, Airfinity built the world’s first dedicated COVID-19 data platform when our leadership identified the need for clean, structured data and independent analysis on the pandemic. Our data quickly became a trusted source with global media citing us an average of 20,000 times annually between 2020-2023.
Airfinity built on this success, launching a biorisk surveillance solution, tracking over 160 infectious diseases to provide risk assessments, simulating and predicting disease outcomes for different populations. This year we launched the world’s first obesity data and analytics platform dedicated to the breakthrough obesity drugs market, a new frontier in global health. We believe our work is pivotal, using data to make better informed decisions and improve outcomes that will increase the global lifespan.
© The content on this page is provided by the profiled company, and remains their copyright.